These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20926601)

  • 1. Characterization of molecular forms of N-terminal B-type natriuretic peptide in vitro.
    Ala-Kopsala M; Moilanen AM; Rysä J; Ruskoaho H; Vuolteenaho O
    Clin Chem; 2010 Dec; 56(12):1822-9. PubMed ID: 20926601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides.
    Ala-Kopsala M; Ruskoaho H; Leppäluoto J; Seres L; Skoumal R; Toth M; Horkay F; Vuolteenaho O
    Clin Chem; 2005 Apr; 51(4):708-18. PubMed ID: 15718490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides.
    Ala-Kopsala M; Magga J; Peuhkurinen K; Leipälä J; Ruskoaho H; Leppäluoto J; Vuolteenaho O
    Clin Chem; 2004 Sep; 50(9):1576-88. PubMed ID: 15265819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating fragments of N-terminal pro-B-type natriuretic peptides in plasma of heart failure patients.
    Foo JY; Wan Y; Schulz BL; Kostner K; Atherton J; Cooper-White J; Dimeski G; Punyadeera C
    Clin Chem; 2013 Oct; 59(10):1523-31. PubMed ID: 23820130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemistry of B-type natriuretic peptide--where are we now?
    Mair J
    Clin Chem Lab Med; 2008; 46(11):1507-14. PubMed ID: 18842106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macro-pro-B-type natriuretic peptide (proBNP) and hidden macro-N-terminal proBNP: Case report.
    Nakagawa Y; Nishikimi T; Sakai H; Ohno S; Kinoshita H; Inazumi H; Moriuchi K; Kuwahara K; Horie M; Kimura T
    Clin Biochem; 2018 Feb; 52():148-152. PubMed ID: 29103929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization of BNP and NT-proBNP Immunoassays in Light of the Diverse and Complex Nature of Circulating BNP-Related Peptides.
    Semenov AG; Feygina EE
    Adv Clin Chem; 2018; 85():1-30. PubMed ID: 29655458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A glycosylated form of the human cardiac hormone pro B-type natriuretic peptide is an intrinsically unstructured monomeric protein.
    Crimmins DL; Kao JL
    Arch Biochem Biophys; 2008 Jul; 475(1):36-41. PubMed ID: 18440296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure.
    Seferian KR; Tamm NN; Semenov AG; Mukharyamova KS; Tolstaya AA; Koshkina EV; Kara AN; Krasnoselsky MI; Apple FS; Esakova TV; Filatov VL; Katrukha AG
    Clin Chem; 2007 May; 53(5):866-73. PubMed ID: 17384012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples.
    Mueller T; Gegenhuber A; Dieplinger B; Poelz W; Haltmayer M
    Clin Chem Lab Med; 2004; 42(8):942-4. PubMed ID: 15387447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure.
    Hammerer-Lercher A; Halfinger B; Sarg B; Mair J; Puschendorf B; Griesmacher A; Guzman NA; Lindner HH
    Clin Chem; 2008 May; 54(5):858-65. PubMed ID: 18339696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of B-Type Natriuretic Peptide Assays: Cross-Reactivity with Different BNP, NT-proBNP, and proBNP Peptides.
    Saenger AK; Rodriguez-Fraga O; Ler R; Ordonez-Llanos J; Jaffe AS; Goetze JP; Apple FS
    Clin Chem; 2017 Jan; 63(1):351-358. PubMed ID: 28062628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling the Molecular Complexity of O-Glycosylated Endogenous (N-Terminal) pro-B-Type Natriuretic Peptide Forms in Blood Plasma of Patients with Severe Heart Failure.
    Halfinger B; Hammerer-Lercher A; Amplatz B; Sarg B; Kremser L; Lindner HH
    Clin Chem; 2017 Jan; 63(1):359-368. PubMed ID: 28062629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposing the High Heterogeneity of Circulating Pro B-Type Natriuretic Peptide Fragments in Healthy Individuals and Heart Failure Patients.
    Amplatz B; Sarg B; Faserl K; Hammerer-Lercher A; Mair J; Lindner HH
    Clin Chem; 2020 Sep; 66(9):1200-1209. PubMed ID: 32797158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure.
    Bruins S; Fokkema MR; Römer JW; Dejongste MJ; van der Dijs FP; van den Ouweland JM; Muskiet FA
    Clin Chem; 2004 Nov; 50(11):2052-8. PubMed ID: 15345664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of NT-proBNP in human urine.
    Palmer SC; Endre ZH; Richards AM; Yandle TG
    Clin Chem; 2009 Jun; 55(6):1126-34. PubMed ID: 19359532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type Natriuretic Peptide circulating forms: Analytical and bioactivity issues.
    Yandle TG; Richards AM
    Clin Chim Acta; 2015 Aug; 448():195-205. PubMed ID: 26160054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers.
    Hammerer-Lercher A; Ludwig W; Falkensammer G; Müller S; Neubauer E; Puschendorf B; Pachinger O; Mair J
    Clin Chem; 2004 Jul; 50(7):1174-83. PubMed ID: 15142976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodetection of glycosylated NT-proBNP circulating in human blood.
    Seferian KR; Tamm NN; Semenov AG; Tolstaya AA; Koshkina EV; Krasnoselsky MI; Postnikov AB; Serebryanaya DV; Apple FS; Murakami MM; Katrukha AG
    Clin Chem; 2008 May; 54(5):866-73. PubMed ID: 18339697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino-terminal proBNP in ovine plasma: evidence for enhanced secretion in response to cardiac overload.
    Pemberton CJ; Yandle TG; Rademaker MT; Charles CJ; Aitken GD; Espiner EA
    Am J Physiol; 1998 Oct; 275(4):H1200-8. PubMed ID: 9746467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.